| Contract Development and Manufacturing Organization (CDMO) | End-to-end pharmaceutical development, validation, regulatory filing and manufacturing for export markets | Integrated IP and regulatory platform, accredited facilities, deep dossier library, exclusive supply agreements | B2B pharma multinational customers and governments in regulated and semi-regulated markets | Commercial supply under long-term agreements, dossiers with regulatory exclusivity | 240 | 63 | Development fees, commercial supply, long-term supply agreements | Contract-based with annuity-like commercial supply revenue streams | Increasing regulatory accreditations, expanded manufacturing facilities, exclusive long-term contracts | Long-term contracts with Noumed, anti-TB Philippines contract |
| Branded Generic Formulations | Pharmaceutical formulations sold domestically and exported under own brands and through distributors | Established domestic institutional relationships, international export channels, wide therapeutic coverage | B2B and B2C including government agencies, hospitals, and retail pharmacy chains | Export branded generics and chronic therapy products | 140 | 37 | Sales to government bodies, hospitals, distributors, and overseas pharma channels | Tender-based institutional sales and trade generics to distributors | Portfolio expansion, distributor network growth, rising export revenues | Noumed OTC brands, Domestic branded generics under proprietary labels |
